Literature DB >> 18797171

Severe congenital myasthenia gravis of the presynaptic type with choline acetyltransferase mutation in a Chinese infant with respiratory failure.

Wai L Yeung1, Ching W Lam, Lai W E Fung, Kam L E Hon, Pak C Ng.   

Abstract

We report a severe case of congenital myasthenia gravis in a Chinese newborn who presented with complete ptosis, severe hypotonia, dysphagia and respiratory insufficiency with recurrent apnea that required mechanical ventilatory support since birth. Routine neurophysiologic studies, including the 3-Hz repetitive stimulation test and electromyogram were normal. Neostigmine and edrophonium tests were also negative. However, decremental response to 3-Hz stimulation became apparent after depleting the muscles with trains of 10-Hz stimuli for 10 min. The infant was subsequently confirmed to have heterozygous mutations in the choline acetyltransferase genes, p.T553N and p.S704P. Both missense mutations are novel mutations. The child remained on positive pressure ventilation at 3 years of age despite treatment with high-dose anticholinesterase. This case highlights the difficulty of making an early diagnosis based on clinical presentation and routine electrophysiologic tests, especially when neonatologists are not familiar with this condition. Further, as there are different genetic defects causing different types of congenital myasthenia gravis, anticholinesterase therapy may be beneficial to some but detrimental to others. Therefore, the exact molecular diagnosis is an important guide to therapy. A high index of suspicion coupled with extended electrodiagnostic tests in clinically suspected patients will ensure the selection of appropriate genetic molecular study for confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797171     DOI: 10.1159/000155612

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  7 in total

1.  Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Authors:  Xin-Ming Shen; Thomas O Crawford; Joan Brengman; Gyula Acsadi; Susan Iannaconne; Emin Karaca; Chaouky Khoury; Jean K Mah; Shimon Edvardson; Zeljko Bajzer; David Rodgers; Andrew G Engel
Journal:  Hum Mutat       Date:  2011-09-23       Impact factor: 4.878

2.  Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations.

Authors:  Ching-Wan Lam; Ka-Sing Wong; Ho-Wan Leung; Chun-Yiu Law
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

3.  A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family.

Authors:  Jia-Ze Tan; Yuan Man; Fei Xiao
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

4.  Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.

Authors:  Trevor M Morey; Warren Winick-Ng; Claudia Seah; R Jane Rylett
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

5.  Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview.

Authors:  Lenie van den Engel-Hoek; Imelda J M de Groot; Bert J M de Swart; Corrie E Erasmus
Journal:  J Neuromuscul Dis       Date:  2015-11-20

6.  Mutation of a serine near the catalytic site of the choline acetyltransferase a gene almost completely abolishes motility of the zebrafish embryo.

Authors:  Swarnima Joshi; Sanamjeet Virdi; Christelle Etard; Robert Geisler; Uwe Strähle
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

7.  Congenital Myasthenic Syndrome Caused by a Novel Hemizygous CHAT Mutation.

Authors:  Yixia Zhang; Xinru Cheng; Chenghan Luo; Mengyuan Lei; Fengxia Mao; Zanyang Shi; Wenjun Cao; Jingdi Zhang; Qian Zhang
Journal:  Front Pediatr       Date:  2020-04-28       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.